Nureca Limited

NSEI:NURECA Stock Report

Market Cap: ₹2.8b

Nureca Management

Management criteria checks 2/4

Nureca's CEO is Aryan Goyal, appointed in Sep 2020, has a tenure of 4.25 years. total yearly compensation is ₹18.75M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 31.56% of the company’s shares, worth ₹891.27M. The average tenure of the management team and the board of directors is 3.1 years and 4.2 years respectively.

Key information

Aryan Goyal

Chief executive officer

₹18.8m

Total compensation

CEO salary percentage100.0%
CEO tenure4.3yrs
CEO ownership31.6%
Management average tenure3.1yrs
Board average tenure4.2yrs

Recent management updates

We Think Nureca Limited's (NSE:NURECA) CEO Compensation Package Needs To Be Put Under A Microscope

Jul 12
We Think Nureca Limited's (NSE:NURECA) CEO Compensation Package Needs To Be Put Under A Microscope

Recent updates

Nureca Limited (NSE:NURECA) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

Sep 06
Nureca Limited (NSE:NURECA) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

We Think Nureca Limited's (NSE:NURECA) CEO Compensation Package Needs To Be Put Under A Microscope

Jul 12
We Think Nureca Limited's (NSE:NURECA) CEO Compensation Package Needs To Be Put Under A Microscope

Nureca Limited (NSE:NURECA) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Mar 29
Nureca Limited (NSE:NURECA) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Nureca Limited's (NSE:NURECA) Shares Not Telling The Full Story

Jun 19
Nureca Limited's (NSE:NURECA) Shares Not Telling The Full Story

Robust Earnings May Not Tell The Whole Story For Nureca (NSE:NURECA)

Jun 23
Robust Earnings May Not Tell The Whole Story For Nureca (NSE:NURECA)

CEO Compensation Analysis

How has Aryan Goyal's remuneration changed compared to Nureca's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-₹28m

Jun 30 2024n/an/a

₹6m

Mar 31 2024₹19m₹19m

-₹18m

Dec 31 2023n/an/a

₹8m

Sep 30 2023n/an/a

₹10m

Jun 30 2023n/an/a

-₹48m

Mar 31 2023₹16m₹16m

-₹82m

Dec 31 2022n/an/a

-₹81m

Sep 30 2022n/an/a

-₹37m

Jun 30 2022n/an/a

₹46m

Mar 31 2022₹11m₹11m

₹450m

Dec 31 2021n/an/a

₹515m

Sep 30 2021n/an/a

₹518m

Jun 30 2021n/an/a

₹731m

Mar 31 2021₹10m₹10m

₹464m

Mar 31 2020₹7m₹7m

₹64m

Compensation vs Market: Aryan's total compensation ($USD220.70K) is above average for companies of similar size in the Indian market ($USD42.34K).

Compensation vs Earnings: Aryan's compensation has increased whilst the company is unprofitable.

CEO

Aryan Goyal (41 yo)

4.3yrs

Tenure

₹18,751,477

Compensation

Mr. Aryan Goyal is Co-Founder of at BioNTech SE and has been its Whole-Time Director since May 28, 2022, also serves as its Chief Executive Officer at Nureca Limited since September 3, 2020. He foray into...

Leadership Team

NamePositionTenureCompensationOwnership
Saurabh Goyal
Co-Founder7.8yrs₹19.23m31.67%
₹ 894.5m
Aryan Goyal
Co-Founder4.3yrs₹18.75m31.56%
₹ 891.3m
Naresh Gupta
Chief Financial Officer1.1yrs₹3.76mno data
Chetna Anand
Company Secretary & Compliance Officer3.1yrs₹1.38mno data
Rajinder Sharma
Whole-Time Director2.6yrs₹300.00kno data
Gurvikram Singh
Assistant Manager of Investors Relations & Corporate Affairs3.1yrs₹260.00kno data
Rohit Saini
Vice President of Sales & Marketing3.6yrsno datano data
Vivek Gupta
Chief Officer Sales & Supply Chainno datano datano data

3.1yrs

Average Tenure

42.5yo

Average Age

Experienced Management: NURECA's management team is considered experienced (3.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Saurabh Goyal
Co-Founder7.8yrs₹19.23m31.67%
₹ 894.5m
Aryan Goyal
Co-Founder2.6yrs₹18.75m31.56%
₹ 891.3m
Rajinder Sharma
Whole-Time Director2.6yrs₹300.00kno data
Vijay Sharma
Independent Director4.2yrs₹600.00kno data
Vikram Chaudhery
Independent Director3.8yrs₹30.00kno data
Charu Singh
Independent Director4.2yrs₹70.00kno data
Ruchita Agarwal
Independent Director4.2yrs₹71.00kno data

4.2yrs

Average Tenure

41yo

Average Age

Experienced Board: NURECA's board of directors are considered experienced (4.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 21:15
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nureca Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution